(Q51932390)

17 April 2018

title

Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications. (English)

1 reference

17 April 2018

main subject

chronic myeloid leukemia

0 references

1 reference

4

1 reference

17 April 2018

author name string

Ingo Roeder

1

1 reference

17 April 2018

Matthias Horn

2

1 reference

17 April 2018

Ingmar Glauche

3

1 reference

17 April 2018

Martin C Mueller

5

1 reference

17 April 2018

Markus Loeffler

6

1 reference

17 April 2018

language of work or name

English

0 references

publication date

1 October 2006

1 reference

17 April 2018

number of pages

4

1 reference

inferred from page(s)

published in

Nature Medicine

1 reference

17 April 2018

volume

12

1 reference

17 April 2018

issue

10

1 reference

17 April 2018

page(s)

1181-1184

1 reference

17 April 2018

https://scigraph.springernature.com/pub.10.1038/nm1487

exact match

0 references

cites work

The biology of normal and neoplastic stem cells in CML.

1 reference

7 January 2021

Chronic myelogenous leukemia.

1 reference

7 January 2021

The tyrosine kinase inhibitor STI571, like interferon-alpha, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia

1 reference

7 January 2021

Current trends in the management of chronic myelogenous leukemia

1 reference

7 January 2021

Molecular responses in patients with chronic myelogenous leukemia in chronic phase treated with imatinib mesylate

1 reference

7 January 2021

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

7 January 2021

Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation

1 reference

7 January 2021

Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase.

1 reference

7 January 2021

Rationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents: implications for pretransplant conditioning

1 reference

7 January 2021

Dynamics of chronic myeloid leukaemia.

1 reference

7 January 2021

Tissue stem cells: definition, plasticity, heterogeneity, self-organization and models--a conceptual approach

1 reference

7 January 2021

A novel dynamic model of hematopoietic stem cell organization based on the concept of within-tissue plasticity.

1 reference

7 January 2021

Competitive clonal hematopoiesis in mouse chimeras explained by a stochastic model of stem cell organization.

1 reference

7 January 2021

Atomic Bomb and Leukemia

1 reference

7 January 2021

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

7 January 2021

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C.

1 reference

7 January 2021

Granulocyte--colony-stimulating factor (Filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase myelogenous leukemia

1 reference

7 January 2021

Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up

1 reference

7 January 2021

Imatinib therapy in chronic myelogenous leukemia: strategies to avoid and overcome resistance

1 reference

7 January 2021

SRCircumventing imatinib resistance

1 reference

7 January 2021

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

1 reference

7 January 2021

The kinetics of clonal dominance in myeloproliferative disorders

1 reference

7 January 2021

Drug resistance in cancer: principles of emergence and prevention

1 reference

7 January 2021

Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM1487

1 reference

17 April 2018

1 reference

17 April 2018